These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17072946)

  • 21. Malignant transformation of hepatic adenomas.
    Micchelli ST; Vivekanandan P; Boitnott JK; Pawlik TM; Choti MA; Torbenson M
    Mod Pathol; 2008 Apr; 21(4):491-7. PubMed ID: 18246041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary hepatic tumors with myxoid change: morphologically unique hepatic adenomas and hepatocellular carcinomas.
    Salaria SN; Graham RP; Aishima S; Mounajjed T; Yeh MM; Torbenson MS
    Am J Surg Pathol; 2015 Mar; 39(3):318-24. PubMed ID: 25602798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of NCAM and c-Kit as hepatic progenitor cell markers for intrahepatic cholangiocarcinomas.
    Xu J; Tan Y; Shao X; Zhang C; He Y; Wang J; Xi Y
    Pathol Res Pract; 2018 Dec; 214(12):2011-2017. PubMed ID: 30301635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are hepatic adenomas premalignant?
    Nagorney DM
    HPB Surg; 1996; 10(1):59-61. PubMed ID: 9187555
    [No Abstract]   [Full Text] [Related]  

  • 25. Malignant transformation of hepatocellular adenoma: report of a case.
    Mouhoub M; Miry A; Haloui A; Karich N; Kamaoui I; Soufi M; Bennani A
    Pan Afr Med J; 2020; 35():92. PubMed ID: 32636990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
    Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
    Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of Dicer1 impairs hepatocyte survival and leads to chronic inflammation and progenitor cell activation.
    Lu XF; Zhou YJ; Zhang L; Ji HJ; Li L; Shi YJ; Bu H
    World J Gastroenterol; 2015 Jun; 21(21):6591-603. PubMed ID: 26074697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined hepatocellular carcinoma and cholangiocarcinoma in a mare.
    Kato M; Higuchi T; Orita Y; Ishikawa Y; Kadota K
    J Comp Pathol; 1997 May; 116(4):409-13. PubMed ID: 9179754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) originating from hepatic progenitor cell: a case report and review of the literature.
    Hu J; Yuan R; Huang C; Shao J; Zou S; Wang K
    World J Surg Oncol; 2016 Aug; 14(1):218. PubMed ID: 27535234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic stem and progenitor cells in liver diseases and hepatocarcinogenesis.
    Heim D; Wege H
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):111-21. PubMed ID: 19305371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells.
    Tummala KS; Brandt M; Teijeiro A; Graña O; Schwabe RF; Perna C; Djouder N
    Cell Rep; 2017 Apr; 19(3):584-600. PubMed ID: 28423321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Road to stemness in hepatocellular carcinoma.
    Flores-Téllez TN; Villa-Treviño S; Piña-Vázquez C
    World J Gastroenterol; 2017 Oct; 23(37):6750-6776. PubMed ID: 29085221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma arising in a telangiectatic hepatocellular adenoma.
    González-Lara MF; Córdova-Ramón JC; Gamboa-Domínguez A; Cosme-Labarthe J; Carrillo-Pérez DL
    Ann Hepatol; 2013; 12(4):626-8. PubMed ID: 23813141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.
    Joo I; Kim H; Lee JM
    Korean J Radiol; 2015; 16(1):50-68. PubMed ID: 25598674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bile ductular cell reaction with senescent hepatocytes in chronic viral hepatitis is lost during hepatocarcinogenesis.
    Ikeda H; Sasaki M; Sato Y; Harada K; Zen Y; Mitsui T; Nakanuma Y
    Pathol Int; 2009 Jul; 59(7):471-8. PubMed ID: 19563410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical characterization of canine hyperplastic hepatic lesions and hepatocellular and biliary neoplasms with monoclonal antibody hepatocyte paraffin 1 and a monoclonal antibody to cytokeratin 7.
    Ramos-Vara JA; Miller MA; Johnson GC
    Vet Pathol; 2001 Nov; 38(6):636-43. PubMed ID: 11732796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas.
    Fujikura K; Yamasaki T; Otani K; Kanzawa M; Fukumoto T; Ku Y; Hirose T; Itoh T; Zen Y
    Am J Surg Pathol; 2016 May; 40(5):689-96. PubMed ID: 26735860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular origin of hepatocellular carcinomas.
    Sell S
    Semin Cell Dev Biol; 2002 Dec; 13(6):419-24. PubMed ID: 12468242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Prognostic Value of Cytokeratin and Sal-Like Protein 4 Expression in Hepatocellular Carcinoma and Intra-Hepatic Cholangiocarcinoma in Taiwan.
    Lai YS; Cheng CC; Lee MT; Chao WT; Lai YC; Hsu YH; Liu YH
    Int J Med Sci; 2018; 15(14):1746-1756. PubMed ID: 30588199
    [No Abstract]   [Full Text] [Related]  

  • 40. [Transformation of hepatic adenoma into hepatocellular carcinoma in patients with prolonged use of oral contraceptives].
    Herman P; Machado MA; Volpe P; Pugliese V; Vianna MR; Bacchella T; Machado MC; Pinotti HW
    Rev Hosp Clin Fac Med Sao Paulo; 1994; 49(1):30-3. PubMed ID: 8029613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.